Stock Research for MRTX


Featured Broker: Ally Invest

Get the due diligence for another stock.


MRTX Stock Chart & Research Data

The MRTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MRTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


MRTX Due diligence Resources & Stock Charts

The MRTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MRTX Detailed Price Forecast - CNN Money CNN View MRTX Detailed Summary - Google Finance
Yahoo View MRTX Detailed Summary - Yahoo! Finance Zacks View MRTX Stock Research & Analysis -

Stock Analysis

TradeIdeas View MRTX Trends & Analysis - Trade-Ideas Barrons View MRTX Major Holders - Barrons
NASDAQ View MRTX Call Transcripts - NASDAQ Seeking View MRTX Breaking News & Analysis - Seeking Alpha
Spotlight View MRTX Annual Report - OTC Report View MRTX OTC Short Report -
TradeKing View MRTX Fundamentals - TradeKing Charts View MRTX SEC Filings - Bar Chart
WSJ View Historical Prices for MRTX - The WSJ Morningstar View Performance/Total Return for MRTX - Morningstar
MarketWatch View the Analyst Estimates for MRTX - MarketWatch CNBC View the Earnings History for MRTX - CNBC
StockMarketWatch View the MRTX Earnings - StockMarketWatch MacroAxis View MRTX Buy or Sell Recommendations - MacroAxis
Bullish View the MRTX Bullish Patterns - American Bulls Short Pains View MRTX Short Pain Metrics -

Social Media Mentions

StockTwits View MRTX Stock Mentions - StockTwits PennyStocks View MRTX Stock Mentions - PennyStockTweets
Twitter View MRTX Stock Mentions - Twitter Invest Hub View MRTX Investment Forum News - Investor Hub
Yahoo View MRTX Stock Mentions - Yahoo! Message Board Seeking Alpha View MRTX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for MRTX - Insider Cow View Insider Transactions for MRTX - Insider Cow
CNBC View MRTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MRTX - OTC Markets
Yahoo View Insider Transactions for MRTX - Yahoo! Finance NASDAQ View Institutional Holdings for MRTX - NASDAQ

Stock Charts

FinViz View MRTX Stock Insight & Charts - StockCharts View MRTX Investment Charts -
BarChart View MRTX Stock Overview & Charts - BarChart Trading View View MRTX User Generated Charts - Trading View

Latest Financial News for MRTX

Mirati Therapeutics Announces The Appointment Of Maya Martinez-Davis To The Board Of Directors
Posted on Monday December 10, 2018

SAN DIEGO , Dec. 10, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced the appointment of Maya Martinez-Davis to the Company's Board ...

Investor Expectations to Drive Momentum within Mirati Therapeutics, comScore, Nuance Communications, Carnival, Aerie Pharmaceuticals, and TrueCar — Discovering Underlying Factors of Influence
Posted on Tuesday December 04, 2018

NEW YORK, Dec. 04, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings
Posted on Friday November 30, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 29) Allakos Inc (NASDAQ: ALLK ) Emergent Biosolutions Inc ...

Mirati Therapeutics Announces FDA Clearance Of Investigational New Drug (IND) Application To Initiate Phase 1/2 Trial Of KRAS G12C Inhibitor, MRTX849
Posted on Thursday November 29, 2018

"KRAS mutations, like the G12C mutation, are recognized as drivers of multiple tumor types, including non-small cell lung cancer and colorectal cancers. Efforts over the last 25 years to develop drugs to inhibit mutant KRAS have been largely unsuccessful," said James Christensen, Ph.D., Chief Scientific Officer, Mirati Therapeutics.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.